- Conditions
- Deep Vein Thrombosis, Pulmonary Embolus
- Interventions
- Enoxaparin, Rivaroxaban
- Drug
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 149,248 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Recruitment Status
Active, not recruiting clinical trials
Status pages show live ClinicalTrials.gov search results by recruitment status, with direct links to official study records plus page-level filtering and sorting.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
6457
Shown on this page
12
Local top conditions
6
Local top sponsors
6
Showing 1–12 of 6,457 matching trials with status Active, not recruiting.
Indexed local directory records.
Top conditions
Top sponsors
Top locations
Top therapies
Indexed official records
Open in full search- Conditions
- Colorectal Cancer, Diverticulitis of Sigmoid
- Interventions
- Fujifilm monitoring
- Device
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- B-cell Acute Lymphoblastic Leukemia
- Interventions
- Blinatumomab, MTX/ARA-C, Mini-CVD
- Drug
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2033
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- HPV Infection
- Interventions
- 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use
- Biological
- Lead sponsor
- Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- Industry
- Eligibility
- 24 Years to 64 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Rockville, Maryland
- Conditions
- Small Cell Lung Cancer
- Interventions
- Durvalumab, Tarlatamab, YL201
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 11
- States / cities
- Irvine, California • New Haven, Connecticut • Tampa, Florida + 7 more
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Cemiplimab, Cetuximab
- Drug
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- BI 770371, Cetuximab, Pembrolizumab
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 3
- States / cities
- Louisville, Kentucky • Minneapolis, Minnesota • Columbus, Ohio
- Conditions
- Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis
- Interventions
- bimekizumab
- Drug
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 89 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2028
- U.S. locations
- 6
- States / cities
- Birmingham, Alabama • Fountain Valley, California • Tampa, Florida + 3 more
- Conditions
- Diabetic Foot Ulcer
- Interventions
- NOX1416 and SOC, SOC (Standard of care)
- Drug · Procedure
- Lead sponsor
- NOxy Health Products, LLC
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 13
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Coral Gables, Florida + 9 more
- Conditions
- Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma, Pancreatic Ductal Adenocarcinoma, Solid Tumor
- Interventions
- IPN01194
- Drug
- Lead sponsor
- Ipsen
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 4
- States / cities
- Los Angeles, California • New Haven, Connecticut • Nashville, Tennessee + 1 more
- Conditions
- Cigarette Smoking-Related Carcinoma, Lung Carcinoma
- Interventions
- Biospecimen Collection, Bronchoscopy, Canakinumab, Carbon Monoxide Measurement, Survey Administration
- Procedure · Biological · Other
- Lead sponsor
- Peter Shields
- Other
- Eligibility
- 40 Years to 73 Years
- Enrollment
- 41 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Asthma
- Interventions
- Amlitelimab, Placebo
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 335 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 8
- States / cities
- Stockton, California • Boynton Beach, Florida • Miami Lakes, Florida + 5 more